Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000051482
JPRN-UMIN000051482CompletedUnknown

Ensitrelvir Fumaric Acid in Hospitalized Patients with SARS-CoV-2 Retrospective Chart Review -Tomita Hospital- - Ensitrelvir Fumaric Acid in Hospitalized Patients with SARS-CoV-2 Retrospective Chart Review -Tomita Hospital

Shionogi & Co., Ltd.0 sites10 target enrollmentStarted: June 30, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Enrollment
10
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patients who meet any of the following criteria are excluded from the study. 1) Patients who were treated off-label 2) Patients who refuse to participate in this study

Investigators

Similar Trials

Recruiting
Unknown
Ensitrelvir Fumaric Acid in Health care workers with SARS-CoV-2 Retrospective Chart Review - Tokyo Rinkai HospitalCOVID-19
JPRN-UMIN000054128SHIONOGI & Co., Ltd.100
Active, not recruiting
Phase 1
Exoxaparin in hospitalized patients with moderate-severe COVID19Hospitalized adult patients with microbiologically confirmed moderate-severe COVID-19 infectionMedDRA version: 20.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: SOCClassification code 10038738Term: Respiratory, thoracic and mediastinal disordersSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2020-001308-40-ITALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA100
Active, not recruiting
Phase 4
Aspirin after hospitalisation with pneumonia to prevent heart attacks and strokePneumonia - lung infectionRespiratory
ISRCTN85630652orth Bristol NHS Trust22,600
Recruiting
Phase 2
Inhaled Prophylactic Heparin in Ventilator Associated Pneumonia Prevention (IPHIVAP)Ventilator Associated PneumoniaRespiratory - Other respiratory disorders / diseasesInfection - Studies of infection and infectious agents
ACTRN12612000038897A/Prof Robert Boots914
Not yet recruiting
Unknown
Antimicrobial Utilization In Hospital
CTRI/2024/06/069303krishnan Prem